Article info
Clinical and epidemiological research
Extended report
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial
- Correspondence to Dr Johan Anders Karlsson, Reumatologiska kliniken, Skånes universitetssjukhus, Lund, Kioskgatan 3, Lund 22185, Sweden; Johan.81.karlsson{at}gmail.com
Citation
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial
Publication history
- Received May 21, 2012
- Accepted October 28, 2012
- First published November 29, 2012.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions